Back to search

University of Nevada - Reno

Molecular mechanisms underlying cerebral small vessel disease associated with mutations in COL4A1

Abstract

dc:description.abstract

Cerebral small vessel diseases (cSVDs) are the leading cause of stroke and vascular dementia, but the underlying pathogenic mechanisms are unknown. Humans and mice with autosomal dominant mutations in the collagen-encoding gene COL4A1 present with brain pathology that typifies cSVD. Data in this thesis reveals divergent pathogenic mechanisms in two Col4a1 mutant mouse models and offers viable therapeutic strategies for treating related cSVDs. Col4a1G1344D cSVD was associated with the loss of myogenic tone due to blunted pressure-induced smooth muscle cell (SMC) depolarization. Dysregulation of membrane potential was linked to impaired Ca2+-dependent activation of transient receptor potential melastatin 4 (TRPM4) channels caused by disruption in sarcoplasmic reticulum (SR) Ca2+ signaling. Deficits were prevented by treating mice with 4-phenylbutyrate, a compound that promotes the trafficking of misfolded proteins from the SR, suggesting accumulation of mutant collagen in the SR contributes to the pathogenesis. The fundamental defect in Col4a1G394V cSVD was the depletion of phosphatidylinositol 4,5 bisphosphate (PIP2), a necessary cofactor for TRPM4 and inwardly-rectifying K+ (KIR) channels, in vascular SMCs and endothelial cells. This caused a loss of myogenic tone and neurovascular coupling contributing to cSVD. PIP2 depletion was linked to increased phosphoinositide 3-kinase (PI3K) activity acting downstream of transforming growth factor-beta (TGF-β) receptors. Restoring PIP2 by blocking PI3K or TGF-β receptors restored myogenic tone, neurovascular coupling, and memory function. Differences in pathogenic mechanisms between mutations within the same gene highlight the diverse causes and the need for specific treatments of cSVDs.

Degree

thesis:*
Level thesis:degree_level
Doctorate Degree
Department thesis:degree_department
Cell and Molecular Pharmacology and Physiology
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Yamasaki, Evan
Advisor dc:contributor.advisor
  • Earley, Scott
Committee members dc:contributor.committeemember
  • Feng Earley, Yumei
  • Harvey, Robert D
  • Perrino, Brian
  • Ferguson, Bradley

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • Creative Commons Attribution 4.0 United States
  • Author(s)

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/11714/8482

Chain of custody

source
Harvested from
University of Nevada - Reno
Base URL
scholarwolf.unr.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Yamasaki, Evan. Molecular mechanisms underlying cerebral small vessel disease associated with mutations in COL4A1. Doctorate Degree thesis, 2023. http://hdl.handle.net/11714/8482